Guidelines to resolve conflicts in treating critically ill patients

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:320 / 320
页数:1
相关论文
共 50 条
  • [31] DOMINIC WILKINSON ON TREATING CRITICALLY ILL CHILDREN
    Wilkinson, Dominic
    TPM-THE PHILOSOPHERS MAGAZINE, 2013, (62): : 125 - 126
  • [32] Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients
    Jacobi, Judith
    Bircher, Nicholas
    Krinsley, James
    Agus, Michael
    Braithwaite, Susan S.
    Deutschman, Clifford
    Freire, Amado X.
    Geehan, Douglas
    Kohl, Benjamin
    Nasraway, Stanley A.
    Rigby, Mark
    Sands, Karen
    Schallom, Lynn
    Taylor, Beth
    Umpierrez, Guillermo
    Mazuski, John
    Schunemann, Holger
    CRITICAL CARE MEDICINE, 2012, 40 (12) : 3251 - 3276
  • [33] Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
    Roberts, Jason A.
    Roberts, Darren M.
    CRITICAL CARE, 2014, 18 (03):
  • [34] A Simulation Curriculum Improves New Intern Confidence in Treating Critically Ill Patients
    Byrne, R. G.
    Nyce, A.
    ANNALS OF EMERGENCY MEDICINE, 2012, 60 (05) : S184 - S185
  • [35] Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro
    Jean-Marie Forel
    Ignacio Martin-Loeches
    Charles-Edouard Luyt
    Intensive Care Medicine, 2014, 40 : 1945 - 1949
  • [36] Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines?
    Jason A Roberts
    Darren M Roberts
    Critical Care, 18
  • [37] Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con
    G. Chanques
    S. Jaber
    Intensive Care Medicine, 2014, 40 : 1950 - 1953
  • [38] Ampicillin/sulbactam: Its potential use in treating infections in critically ill patients
    Adnan, Syamhanin
    Paterson, David L.
    Lipman, Jeffrey
    Roberts, Jason A.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (05) : 384 - 389
  • [39] Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: con
    Chanques, G.
    Jaber, S.
    INTENSIVE CARE MEDICINE, 2014, 40 (12) : 1950 - 1953
  • [40] Treating HSV and CMV reactivations in critically ill patients who are not immunocompromised: pro
    Forel, Jean-Marie
    Martin-Loeches, Ignacio
    Luyt, Charles-Edouard
    INTENSIVE CARE MEDICINE, 2014, 40 (12) : 1945 - 1949